Funding for this research was provided by:
National Institute on Aging (42856, 43885, 25688)
Received: 28 July 2017
Accepted: 16 October 2017
First Online: 2 November 2017
Ethics approval and consent to participate
: This study was approved by the Emory Institutional Review Board (number 66145). Informed consent was obtained from all subjects or their authorized representatives.
: Not applicable.
: WTH has a patent (assignee, Emory University) on the use of CSF p/t-tau ratio in the evaluation of frontotemporal lobar degeneration, has received research support from Avid Pharmaceuticals, and has received travel support from Eli Lilly and Hoffman-La Roche. DQ has received research support from Medtronic and Siemens Healthcare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.